1023 related articles for article (PubMed ID: 28712855)
21. Cardiac and Stress Biomarkers and Chronic Kidney Disease Progression: The CRIC Study.
Bansal N; Zelnick L; Shlipak MG; Anderson A; Christenson R; Deo R; deFilippi C; Feldman H; Lash J; He J; Kusek J; Ky B; Seliger S; Soliman EZ; Go AS;
Clin Chem; 2019 Nov; 65(11):1448-1457. PubMed ID: 31578216
[TBL] [Abstract][Full Text] [Related]
22. Added value of soluble tumor necrosis factor-α receptor 1 as a biomarker of ESRD risk in patients with type 1 diabetes.
Forsblom C; Moran J; Harjutsalo V; Loughman T; Wadén J; Tolonen N; Thorn L; Saraheimo M; Gordin D; Groop PH; Thomas MC;
Diabetes Care; 2014 Aug; 37(8):2334-42. PubMed ID: 24879837
[TBL] [Abstract][Full Text] [Related]
23. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
[TBL] [Abstract][Full Text] [Related]
24. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death.
Apple FS; Murakami MM; Pearce LA; Herzog CA
Clin Chem; 2004 Dec; 50(12):2279-85. PubMed ID: 15364888
[TBL] [Abstract][Full Text] [Related]
25. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
[TBL] [Abstract][Full Text] [Related]
26. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
Astrup AS; Tarnow L; Rossing P; Hansen BV; Hilsted J; Parving HH
Diabetes Care; 2006 Feb; 29(2):334-9. PubMed ID: 16443883
[TBL] [Abstract][Full Text] [Related]
27. Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Tarnow L; Gall MA; Hansen BV; Hovind P; Parving HH
Diabetologia; 2006 Oct; 49(10):2256-62. PubMed ID: 16937127
[TBL] [Abstract][Full Text] [Related]
28. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
Foster MC; Inker LA; Hsu CY; Eckfeldt JH; Levey AS; Pavkov ME; Myers BD; Bennett PH; Kimmel PL; Vasan RS; Coresh J; Nelson RG;
Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
[TBL] [Abstract][Full Text] [Related]
29. Use of High-Sensitivity Troponin T to Identify Patients With Acute Heart Failure at Lower Risk for Adverse Outcomes: An Exploratory Analysis From the RELAX-AHF Trial.
Pang PS; Teerlink JR; Voors AA; Ponikowski P; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Kriger J; Prescott MF; Hua TA; Severin T; Metra M
JACC Heart Fail; 2016 Jul; 4(7):591-599. PubMed ID: 27039129
[TBL] [Abstract][Full Text] [Related]
30. Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
Peeters SA; Engelen L; Buijs J; Jorsal A; Parving HH; Tarnow L; Rossing P; Schalkwijk CG; Stehouwer CDA
Cardiovasc Diabetol; 2017 Apr; 16(1):55. PubMed ID: 28446168
[TBL] [Abstract][Full Text] [Related]
31. Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors.
Andrésdóttir G; Jensen ML; Carstensen B; Parving HH; Rossing K; Hansen TW; Rossing P
Diabetes Care; 2014 Jun; 37(6):1660-7. PubMed ID: 24623028
[TBL] [Abstract][Full Text] [Related]
32. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
Saulnier PJ; Dieter BP; Tanamas SK; McPherson SM; Wheelock KM; Knowler WC; Looker HC; Meek RL; Nelson RG; Tuttle KR
Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
[TBL] [Abstract][Full Text] [Related]
33. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
Theilade S; Hansen TW; Goetze JP; Rossing P
Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular disease biomarkers are associated with declining renal function in type 2 diabetes.
Jenks SJ; Conway BR; McLachlan S; Teoh WL; Williamson RM; Webb DJ; Welsh P; Sattar N; Strachan MWJ; Price JF
Diabetologia; 2017 Aug; 60(8):1400-1408. PubMed ID: 28528401
[TBL] [Abstract][Full Text] [Related]
35. Midregional-proAtrial Natriuretic Peptide and High Sensitive Troponin T Strongly Predict Adverse Outcome in Patients Undergoing Percutaneous Repair of Mitral Valve Regurgitation.
Wöhrle J; Karakas M; Trepte U; Seeger J; Gonska B; Koenig W; Rottbauer W
PLoS One; 2015; 10(9):e0137464. PubMed ID: 26368980
[TBL] [Abstract][Full Text] [Related]
36. Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality.
Löwbeer C; Stenvinkel P; Pecoits-Filho R; Heimbürger O; Lindholm B; Gustafsson SA; Seeberger A
J Intern Med; 2003 Feb; 253(2):153-60. PubMed ID: 12542555
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
[TBL] [Abstract][Full Text] [Related]
38. Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes.
von Scholten BJ; Reinhard H; Hansen TW; Lindhardt M; Petersen CL; Wiinberg N; Hansen PR; Parving HH; Jacobsen PK; Rossing P
Cardiovasc Diabetol; 2015 May; 14():59. PubMed ID: 25990319
[TBL] [Abstract][Full Text] [Related]
39. Single and multiple cardiovascular biomarkers in subjects without a previous cardiovascular event.
Pareek M; Bhatt DL; Vaduganathan M; Biering-Sørensen T; Qamar A; Diederichsen AC; Møller JE; Hindersson P; Leósdóttir M; Magnusson M; Nilsson PM; Olsen MH
Eur J Prev Cardiol; 2017 Oct; 24(15):1648-1659. PubMed ID: 28644092
[TBL] [Abstract][Full Text] [Related]
40. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy.
Jorsal A; Tarnow L; Frystyk J; Lajer M; Flyvbjerg A; Parving HH; Vionnet N; Rossing P
Kidney Int; 2008 Sep; 74(5):649-54. PubMed ID: 18496510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
